Gene · 3093
Papers3,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Does Testicular Sperm Alter Reproductive and Perinatal Outcomes in Assisted Reproductive Technology Cycles? 10 Years' Experience in an Indian Clinic. | J Hum Reprod Sci | 2022 | 37033133 | PubTator, text mining | PubMed |
| A comparative assessment of RNF38 and P53 genes expression in the sperm samples obtained from males with normozoospermia and asthenospermia: A case-control study. | Int J Reprod Biomed | 2022 | 36819206 | PubTator, text mining | PubMed |
| Meta-analysis of transcriptomics data identifies potential biomarkers and their associated regulatory networks in gallbladder cancer. | Gastroenterol Hepatol Bed Bench | 2022 | 36762219 | PubTator, text mining | PubMed |
| Identification of ULK1 as a novel mitophagy-related gene in diabetic nephropathy. | Front Endocrinol (Lausanne) | 2022 | 36743936 | PubTator, text mining | PubMed |
| Identification of autophagy-associated genes and prognostic implications in adults with acute myeloid leukemia by integrated bioinformatics analysis. | Front Oncol | 2022 | 36727051 | PubTator, text mining | PubMed |
| Non-coding RNA and autophagy: Finding novel ways to improve the diagnostic management of bladder cancer. | Front Genet | 2022 | 36685879 | PubTator, text mining | PubMed |
| Integrated Profiles of Transcriptome and mRNA m6A Modification Reveal the Intestinal Cytotoxicity of Aflatoxin B1 on HCT116 Cells. | Genes (Basel) | 2022 | 36672820 | PubTator, text mining | PubMed |
| Analyzing the multi-target pharmacological mechanism of folium Artemisia argyi acting on breast cancer: a network pharmacology approach. | Ann Transl Med | 2022 | 36660662 | PubTator, text mining | PubMed |
| Pan-cancer analyses of Jab1/COPS5 reveal oncogenic role and clinical outcome in human cancer. | Heliyon | 2022 | 36643321 | PubTator, text mining | PubMed |
| Using network pharmacology and molecular docking verification to explore the mechanism of ursolic acid in the treatment of osteoporosis. | Medicine (Baltimore) | 2022 | 36626454 | PubTator, text mining | PubMed |
| Wogonin increases gemcitabine sensitivity in pancreatic cancer by inhibiting Akt pathway. | Front Pharmacol | 2022 | 36618921 | PubTator, text mining | PubMed |
| Circulating miRNA Expression Profiles and Machine Learning Models in Association with Response to Irinotecan-Based Treatment in Metastatic Colorectal Cancer. | Int J Mol Sci | 2022 | 36613487 | PubTator, text mining | PubMed |
| Hsa_circ_0015278 Regulates FLT3-ITD AML Progression via Ferroptosis-Related Genes. | Cancers (Basel) | 2022 | 36612069 | PubTator, text mining | PubMed |
| Installation of electrophiles onto the C-terminus of recombinant ubiquitin and ubiquitin-like proteins. | Chem Sci | 2022 | 36605735 | PubTator, text mining | PubMed |
| Modeling of emergency support capacity and optimization of delivery service system for urban living materials under uncertain situations: a case study of Xi'an City during COVID-19 epidemic. | Comput Urban Sci | 2022 | 36589308 | PubTator, text mining | PubMed |
| USPs in Pancreatic Ductal Adenocarcinoma: A Comprehensive Bioinformatic Analysis of Expression, Prognostic Significance, and Immune Infiltration. | Biomed Res Int | 2022 | 36582601 | PubTator, text mining | PubMed |
| Identification of immune microenvironment subtypes and signature genes for Alzheimer's disease diagnosis and risk prediction based on explainable machine learning. | Front Immunol | 2022 | 36569892 | PubTator, text mining | PubMed |
| Ferroptosis and triple-negative breast cancer: Potential therapeutic targets. | Front Oncol | 2022 | 36568247 | PubTator, text mining | PubMed |
| Exploring the Effective Components and Mechanism of Action of Japanese Ardisia in the Treatment of Autoimmune Hepatitis Based on Network Pharmacology and Experimental Verification. | Pharmaceuticals (Basel) | 2022 | 36558908 | PubTator, text mining | PubMed |
| Antiviral Potential of Small Molecules Cordycepin, Thymoquinone, and N6, N6-Dimethyladenosine Targeting SARS-CoV-2 Entry Protein ADAM17. | Molecules | 2022 | 36558177 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3093/papers?page=25